AU5353969A - Antacid composition - Google Patents

Antacid composition

Info

Publication number
AU5353969A
AU5353969A AU53539/69A AU5353969A AU5353969A AU 5353969 A AU5353969 A AU 5353969A AU 53539/69 A AU53539/69 A AU 53539/69A AU 5353969 A AU5353969 A AU 5353969A AU 5353969 A AU5353969 A AU 5353969A
Authority
AU
Australia
Prior art keywords
antacid composition
antacid
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU53539/69A
Other versions
AU438147B2 (en
Inventor
Richard Brown Garland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5353969A publication Critical patent/AU5353969A/en
Application granted granted Critical
Publication of AU438147B2 publication Critical patent/AU438147B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12Magnesium silicate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU53539/69A 1968-04-18 1969-04-16 Antacid composition Expired AU438147B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72217668A 1968-04-18 1968-04-18
USUS722,176 1968-04-18
US78572768A 1968-12-20 1968-12-20
USUS785,727 1968-12-20

Publications (2)

Publication Number Publication Date
AU5353969A true AU5353969A (en) 1970-10-22
AU438147B2 AU438147B2 (en) 1973-07-18

Family

ID=27110553

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53539/69A Expired AU438147B2 (en) 1968-04-18 1969-04-16 Antacid composition

Country Status (15)

Country Link
JP (1) JPS4621672B1 (en)
AU (1) AU438147B2 (en)
BE (1) BE731695A (en)
CA (1) CA959760A (en)
CH (1) CH536114A (en)
DE (1) DE1919802A1 (en)
DK (1) DK127269B (en)
ES (1) ES366173A1 (en)
FI (1) FI50831C (en)
FR (1) FR2007475A1 (en)
GB (1) GB1269987A (en)
IL (1) IL32020A (en)
NL (1) NL6906087A (en)
NO (1) NO129077B (en)
SE (1) SE388356B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1401257A (en) * 1972-06-30 1975-07-16 Miles Lab Process for preparing a spray dried calcium carbonate composition
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
SE7905972L (en) * 1979-07-09 1981-01-10 Haessle Ab PROCEDURE FOR THE PREPARATION OF Gastric Acid-Neutralizing Agents, Gastric Acid-Neutralizing Agents, AND METHOD OF TREATING HYPERACIDITY AND RELATED DISEASE CONDITIONS
SG72632A1 (en) * 1985-04-18 2000-05-23 Procter & Gamble Treatment of non-ulcer dyspepsia with bismuth salts
IT1215332B (en) * 1987-01-12 1990-02-08 Crinos Industria Farmaco PHARMACEUTICAL COMPOSITION CONTAINING SULGLICOTIDE FOR THERAPY OF GASTRIC ULCER
DE3812378A1 (en) * 1988-04-14 1989-10-26 Theo Mertens Mobile device for grinding and mixing harvested crops
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
DE4305919A1 (en) * 1993-02-26 1994-09-01 Ruediger Potthoff Transporting hopper for plastics granulate
CN100400050C (en) 2002-02-04 2008-07-09 麦克尼尔-Ppc股份有限公司 Stable pharmaceutical composition useful for treating gastrointestinal disorders
CA2477964A1 (en) * 2002-03-04 2003-09-12 Medrx Co., Ltd. Liquid matrix transforming its phase in living body and oral liquid preparation
US20030232092A1 (en) * 2002-06-14 2003-12-18 Hasenmayer Donald L. Liquid antacid compositions
EP3137059B1 (en) 2014-04-29 2018-05-23 The Procter and Gamble Company Method for making bismuth-containing liquid pharmaceutical suspensions
CA2943422C (en) 2014-04-29 2020-03-10 The Procter & Gamble Company Bismuth-containing liquid pharmaceutical suspensions
CN114732828A (en) * 2022-04-27 2022-07-12 广西南宁百会药业集团有限公司 Hydrotalcite suspension and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621147A (en) *

Also Published As

Publication number Publication date
FR2007475A1 (en) 1970-01-09
DE1919802A1 (en) 1969-11-06
CH536114A (en) 1973-04-30
DK127269B (en) 1973-10-15
BE731695A (en) 1969-10-20
CA959760A (en) 1974-12-24
SE388356B (en) 1976-10-04
IL32020A0 (en) 1969-06-25
IL32020A (en) 1972-11-28
FI50831B (en) 1976-04-30
NL6906087A (en) 1969-10-21
JPS4621672B1 (en) 1971-06-19
FI50831C (en) 1976-08-10
ES366173A1 (en) 1971-04-01
GB1269987A (en) 1972-04-12
NO129077B (en) 1974-02-25
AU438147B2 (en) 1973-07-18

Similar Documents

Publication Publication Date Title
CA960796A (en) Hydrocurable oxazolidine-isocyanate compositions
AU438147B2 (en) Antacid composition
AU443154B2 (en) Concentrated liquid antacid compositions
CA930669A (en) Compositions anti-acneiques
AU7592574A (en) Compositions
CA971879A (en) Concentrated antacid composition
AU1586770A (en) Antacid compositions
AU440535B2 (en) Antacid compositions
CA793267A (en) Ethylenediamine-anisole paint-stripping compositions
AU430619B2 (en) Leak-stopping composition
CA786780A (en) Composition tinctoriale
AU444549B2 (en) Inseciticidal composition
CA780841A (en) Prednisolone-neomycin composition
AU436490B2 (en) Anti-dermatophytosic composition
AU452260B2 (en) Composition
CA776134A (en) Antacid methods and compositions
CA923818A (en) Antacid compositions
AU5759369A (en) Composition
AU5430869A (en) Inseciticidal composition
AU5821269A (en) Composition
AU5140169A (en) Composition
AU5646169A (en) Leak-stopping composition
AU4918769A (en) Composition
AU5240369A (en) Anti-dermatophytosic composition
CA851160A (en) Antacid compositions